Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. (Q41975229)
Jump to navigation
Jump to search
scientific article published on April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. |
scientific article published on April 2014 |
Statements
1 reference
Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. (English)
1 reference
T E Coyle
1 reference
M T Reding
1 reference
J C Lin
1 reference
L A Michaels
1 reference
A Shah
1 reference
J Powell
1 reference
1 April 2014
1 reference
1 reference
488-496
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference